Tenants in the news: Shire

November 2nd, 2015

LTC tenant Shire recently announced it had agreed to acquire Burlington-based Dyax Corporation for $6.5 billion.

LTC tenant Shire recently announced it had agreed to acquire Burlington-based Dyax Corporation for $6.5 billion. Dyax develops treatments for the rare genetic condition known as hereditary angioedema.

“The highly complementary transaction aligns with and accelerates our strategy to build a global biotechnology company focused on rare diseases and specialty conditions,” Shire CEO Flemming Ornskov said.

Read the company’s full press release for more on the deal.